CLINICAL_TRIALS trial_result · 2010-02-04

Clinical Trial Update: Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia [Phase 2]

Phase 2 safety and efficacy study of an oxazolidinone to treat community-acquired pneumonia; trial completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Melinta Therapeutics, Inc. | Conditions: Community-Acquired Pneumonia (CAP) | Phase 2 | Status: COMPLETED | Results posted: 2010-02-04